A pulmonary embolism (PE) represents a sudden blockage in one of the pulmonary arteries within the lungs. This obstruction typically originates as a blood clot, known as a thrombus, which travels through the bloodstream. The most common source for this traveling clot, or embolus, is a Deep Vein Thrombosis (DVT) in the deep veins of the legs. Because the chest X-ray is often the first imaging test performed in an emergency, patients frequently ask if it can reliably detect PE. While the X-ray is immediate and widely available, its primary role is to assess the surrounding chest cavity for other possible causes of a patient’s symptoms.
Understanding Pulmonary Embolism
A pulmonary embolism occurs when a clot, most often a fragment of a DVT, travels through the venous system and the right side of the heart, eventually lodging in a pulmonary artery. This mechanical blockage prevents blood from reaching a section of the lung, which is known as perfusion. The affected lung tissue is still receiving air, but the essential gas exchange of oxygen and carbon dioxide cannot take place without blood flow, leading to a ventilation-perfusion mismatch.
The severity depends largely on the size and number of clots, which directly impacts the restriction of blood flow. A large clot can cause a sudden increase in pressure on the right side of the heart, sometimes leading to right ventricular failure, which is the most frequent cause of death in severe PE cases. This obstruction can also cause damage to the lung tissue itself, known as pulmonary infarction, if the blood supply is completely cut off.
Limitations of the Chest X-Ray
The fundamental limitation of the standard chest X-ray in diagnosing a pulmonary embolism lies in its inability to directly visualize the clot. A blood clot is a soft tissue structure, and X-rays are better at distinguishing between structures with different densities, such as bone, air-filled lung tissue, and fluid. Since the clot is composed of similar density material to the surrounding blood and soft tissue of the lung, it is radiographically “invisible” on a plain film.
Although the clot itself is not visible, a PE can sometimes cause secondary changes in the lung tissue that appear on the X-ray. These indirect signs are often subtle and lack specificity, meaning they can also be caused by other lung diseases. For example, the presence of a Westermark sign, which is an area of increased lung clarity due to decreased blood flow (oligemia), is observed in only about 8% to 14% of confirmed PE cases.
Another recognized but rare finding is Hampton’s Hump, which presents as a wedge-shaped opacity at the edge of the lung, representing lung tissue infarction. This sign has a low sensitivity, appearing in only about 22% of PE cases, although its presence is more suggestive of the diagnosis. Other non-specific findings, such as an elevated diaphragm or a small pleural effusion (fluid around the lung), are common in PE but also in numerous other conditions. Therefore, while a chest X-ray may be abnormal in a high percentage of PE patients, its findings are poor predictors and cannot be used to definitively confirm or exclude the diagnosis.
The X-Ray’s Primary Diagnostic Function
Despite its poor ability to detect the clot, the chest X-ray remains a standard initial test in the evaluation of a patient with suspected pulmonary embolism. Its primary function is a process known as differential diagnosis, which involves ruling out other conditions that present with similar symptoms. Symptoms of a PE, such as sudden shortness of breath and chest pain, overlap significantly with other acute cardiopulmonary issues.
The X-ray can quickly and accurately identify several diseases that mimic a PE, including pneumonia, a collapsed lung (pneumothorax), or fluid accumulation from heart failure (pulmonary edema). If the chest X-ray shows a clear alternative diagnosis, the clinical focus may shift away from the possibility of a PE. Furthermore, a normal chest X-ray in a patient with unexplained low blood oxygen levels raises the suspicion of a PE, prompting the need for more specific testing. This initial screening step is also important for interpreting the results of a subsequent V/Q scan, as existing lung abnormalities can affect the scan’s results.
Definitive Imaging for Confirmation
When clinical suspicion for a pulmonary embolism remains high, or the X-ray is inconclusive, advanced imaging modalities are required for definitive diagnosis. The current gold standard test is the Computed Tomography Pulmonary Angiogram (CTPA). This specialized CT scan uses a powerful X-ray beam combined with intravenous (IV) contrast dye, which contains iodine, to visualize the pulmonary arteries.
The contrast dye is injected rapidly and travels through the bloodstream, brightly illuminating the blood vessels on the resulting images. A PE is then directly visualized as a filling defect, appearing as a dark area within the bright, contrast-filled artery. The CTPA is highly accurate, with both high sensitivity and specificity for detecting clots, even those in smaller branches of the arteries.
In cases where a patient cannot safely receive the contrast dye—such as those with severe kidney impairment or a history of allergic reaction—a Ventilation/Perfusion (V/Q) scan is used as an alternative. This nuclear medicine test compares the distribution of air (ventilation) and blood flow (perfusion) in the lungs using two different radioactive tracers. A pattern of normal ventilation but defective perfusion strongly suggests a pulmonary embolism, indicating an issue with blood flow despite adequate airflow.